Association of adverse effects with monoamine oxidase type B inhibitor and catechol-o-methyl transferase inhibitor combination therapy in Parkinson’s disease patients
Advances in Parkinson's Disease · 2012
DOI: 10.4236/apd.2012.11002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Parkinson's Disease, 2012. Verfasst von Rui Zhang und 3 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhang, R., Spengler, D. C., Saint-Hilaire, M., & Hohler, A. D. (2012). Association of adverse effects with monoamine oxidase type B inhibitor and catechol-o-methyl transferase inhibitor combination therapy in Parkinson’s disease patients. Advances in Parkinson's Disease. https://doi.org/10.4236/apd.2012.11002
Vancouver
Zhang R, Spengler DC, Saint-Hilaire M, Hohler AD. Association of adverse effects with monoamine oxidase type B inhibitor and catechol-o-methyl transferase inhibitor combination therapy in Parkinson’s disease patients. Advances in Parkinson's Disease. 2012. doi:10.4236/apd.2012.11002
BibTeX
@article{Zhang2012,
author = {Zhang, Rui and Spengler, Danielle C. and Saint-Hilaire, Marie-Helene and Hohler, Anna D.},
title = {Association of adverse effects with monoamine oxidase type B inhibitor and catechol-o-methyl transferase inhibitor combination therapy in Parkinson’s disease patients},
journal = {Advances in Parkinson's Disease},
year = {2012},
doi = {10.4236/apd.2012.11002}
}
EUVIMED